[ad_1] The abundance of Walgreens and CVS Health stores makes them convenient for whenever Shriya Raghavan,…
Tag: Biotech and Pharmaceuticals
Mpox vaccine maker Bavarian Nordic seeks ‘critical’ EU approval for teens after WHO declares health emergency
[ad_1] Jackyenjoyphotography | Moment | Getty Images LONDON — Danish biotech company Bavarian Nordic said Friday…
Health stocks jump as WHO declares mpox global health emergency
[ad_1] Colorized transmission electron micrograph of monkeypox virus particles (red) found within an infected cell (blue),…
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
[ad_1] An Eli Lilly & Co. Zepbound injection pen, March 28, 2024. Bloomberg | Bloomberg |…
Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs
[ad_1] Zoom In IconArrows pointing outwards The direct-to-consumer health-care startup Ro launched a new free tool…
Eli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar
[ad_1] Eli Lilly on Thursday reported second-quarter earnings and revenue that blew past expectations and hiked…
Eli Lilly reports earnings Thursday. Here’s what Wall Street is watching
[ad_1] Investors want to know whether Eli Lilly is seeing the same pricing pressures on its…
CVS slashes profit guidance, will cut $2 billion in expenses as insurance costs climb
[ad_1] The CVS pharmacy logo is displayed on a sign above a CVS Health Corp. store…
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
[ad_1] President Joe Biden speaks during an event at the National Institutes of Health in Bethesda,…
Eli Lilly’s Zepbound and Mounjaro now available in U.S. after shortages, FDA says
[ad_1] An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York…
Eli Lilly’s weight loss drug Zepbound cuts heart failure risks in late-stage study
[ad_1] An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New…
Biogen beats expectations, hikes outlook as Alzheimer’s drug Leqembi and other new products gain traction
[ad_1] A test tube is seen in front of displayed Biogen logo in this illustration taken…
Moderna beats estimates but slashes guidance on low EU sales, competitive U.S. vaccine market
[ad_1] Moderna on Thursday reported second-quarter revenue that beat expectations but slashed its full-year sales guidance,…